A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

PHASE3TerminatedINTERVENTIONAL
Enrollment

627

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Age-Related Macular Degeneration
Interventions
DRUG

E10030

DRUG

ranibizumab

DRUG

E10030 sham intravitreal injection

Pressure on the eye with a syringe with no needle

Trial Locations (121)

1076

Budapest

1106

Budapest

1133

Budapest

2000

Santa Fe

Sydney

2145

Westmead

2150

Parramatta

2600

Glostrup Municipality

3002

East Melbourne

3144

Malvern

4000

Roskilde

5000

Córdoba

Odense

6009

Nedlands

6100

Ankara

6720

Szeged

7621

Pécs

8000

Aarhus C

8200

Magyarszék

9000

Aalborg

10022

New York

13008

Marseille

13224

Syracuse

20246

Hamburg

21209

Baltimore

21740

Hagerstown

23226

Richmond

23454

Virginia Beach

23538

Lübeck

24105

Kiel

27157

Winston-Salem

28210

Charlotte

28803

Asheville

29169

West Columbia

29605

Greenville

30322

Atlanta

30909

Augusta

31008

Navarro

31096

Haifa

32806

Orlando

33308

Fort Lauderdale

33426

Boynton Beach

33770

Largo

33912

Fort Myers

35016

Las Palmas

35100

Izmir

35340

Izmir

37000

Tours

37075

Göttingen

37203

Nashville

44122

Cleveland

44130

Cleveland

46015

Valencia

48006

Bilbao

48145

Münster

48165

Münster

49100

Petah Tikva

50266

West Des Moines

50924

Cologne

52057

Aachen

53127

Bonn

55131

Mainz

55435

Minneapolis

57701

Rapid City

60426

Harvey

64239

Tel Aviv

66204

Shawnee Mission

67091

Strasbourg

67214

Wichita

69003

Lyon

69120

Heidelberg

69317

Lyon

72076

Tübingen

73104

Oklahoma City

75006

Paris

75015

Paris

75019

Paris

75231

Dallas

75745

Paris

76100

Rouen

Rehovot

76131

Karlsruhe

77030

Houston

78233

San Antonio

78240

San Antonio

78503

McAllen

78705

Austin

79106

Freiburg im Breisgau

80045

Aurora

80336

München

80401

Golden

81675

München

84107

Salt Lake City

85704

Tucson

85710

Tucson

91120

Jerusalem

92093

La Jolla

92354

Loma Linda

92705

Santa Ana

93720

Fresno

94010

Créteil

94040

Mountain View

95819

Sacramento

98004

Bellevue

110311

Bogotá

4428164

Kfar Saba

76001000

Santiago de Cali

01960

Peabody

01605

Worcester

08648

Lawrenceville

B1629ODT

Buenos Aires

C1015ABO

Buenos Aires

C1120AAN

Buenos Aires

C1122AAI

Buenos Aires

Unknown

Medellín

D-04103

Leipzig

H-1083

Budapest

H-1145

Budapest

H-4012

Debrecen

08022

Barcelona

08195

Sant Cugat del Vallès

Sponsors
All Listed Sponsors
lead

Ophthotech Corporation

INDUSTRY